ArticleGenes & genomics2025
Triptonide suppresses the FOXK1/AKT2 axis to reverse malignant phenotype and improve cisplatin efficacy in esophageal squamous cell carcinoma.
Xiaoxu Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it